Literature DB >> 14965273

The primary ligand-binding interaction at the GLP-1 receptor is via the putative helix of the peptide agonists.

Suleiman Al-Sabah1, Dan Donnelly.   

Abstract

The N-terminal domain of the GLP-1 receptor binds the putative helical region of the peptide agonists, GLP-1 and exendin-4. Here we demonstrate that this interaction also determines the magnitude of a separate interaction between the N-terminus of these peptides and the receptor's core domain. Enhancing the pre-formation of the C-terminal Trp-Cage motif of exendin-4, a motif critical for high-affinity binding, results in no improvement in receptor affinity, suggesting that this motif forms after the initial peptide-receptor binding event.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14965273     DOI: 10.2174/0929866043478365

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  7 in total

1.  Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Emilia E Savage; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

Review 2.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Extending residence time and stability of peptides by protected graft copolymer (PGC) excipient: GLP-1 example.

Authors:  Gerardo M Castillo; Sandra Reichstetter; Elijah M Bolotin
Journal:  Pharm Res       Date:  2011-08-04       Impact factor: 4.200

4.  Insights into the structural basis of endogenous agonist activation of family B G protein-coupled receptors.

Authors:  Maoqing Dong; Fan Gao; Delia I Pinon; Laurence J Miller
Journal:  Mol Endocrinol       Date:  2008-03-27

5.  Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro.

Authors:  Joakim E Swedberg; Christina I Schroeder; Justin M Mitchell; David P Fairlie; David J Edmonds; David A Griffith; Roger B Ruggeri; David R Derksen; Paula M Loria; David A Price; Spiros Liras; David J Craik
Journal:  J Biol Chem       Date:  2016-05-10       Impact factor: 5.157

6.  Peptide nanomedicines for treatment of acute lung injury.

Authors:  Ruxana T Sadikot
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

7.  A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator.

Authors:  Andreas Jodal; Brigitte Lankat-Buttgereit; Maarten Brom; Roger Schibli; Martin Béhé
Journal:  EJNMMI Res       Date:  2014-06-22       Impact factor: 3.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.